Acromegaly is a condition caused by excess growth hormone in adults. Learn about the common warning signs, bone changes, and risk factors associated with this rare disorder.
Send us all your questions or requests, and our expert team will assist you.
Understanding the symptoms and hormonal profile of acromegaly is essential for patients and clinicians alike, especially when the condition originates from excess growth hormone production in the pituitary gland. This page is designed for international patients who suspect hormonal imbalances, as well as for caregivers seeking clear information about what to expect. Worldwide, acromegaly affects roughly 3–4 people per million, yet many remain undiagnosed for years because early signs are subtle. By recognizing the hallmark manifestations and the underlying endocrine disturbances, patients can pursue timely evaluation at Liv Hospital, where a multidisciplinary team offers comprehensive care.
In the sections that follow, we will detail the physiological mechanisms driving the disease, enumerate the most common physical and systemic signs, describe the laboratory and imaging tests used to confirm the diagnosis, and outline both medical and surgical treatment pathways. Whether you are planning a health‑check abroad or have already received a preliminary diagnosis, the information below will help you navigate the journey from symptom recognition to effective management.
Acromegaly originates from a benign tumor—most often a pituitary adenoma—that secretes excessive amounts of growth hormone (GH). The surplus GH stimulates the liver to produce insulin‑like growth factor‑1 (IGF‑1), which in turn drives tissue overgrowth and metabolic alterations. This hormonal cascade is the foundation for the diverse symptoms and hormonal disturbances observed in patients.
The disease progresses slowly, allowing the body to adapt to rising hormone levels before obvious signs appear. Key mechanisms include:
A concise comparison of hormonal levels in healthy individuals versus those with acromegaly is shown below:
Recognizing this hormonal backdrop is crucial because it informs both the clinical suspicion and the selection of targeted therapies that aim to normalize GH and IGF‑1 levels.
The most recognizable symptoms and hormonal manifestations involve visible changes in bone and soft‑tissue structures. Patients often notice these alterations gradually, attributing them to normal aging or weight gain.
Enlargement of the jaw (prognathism), thickened lips, and a broader nose are classic facial signs. The hands and feet may increase in size, leading to a need for larger footwear and rings. These changes are caused by periosteal bone growth stimulated by IGF‑1.
Skin often becomes oily and thickened, with a tendency toward excessive sweating (hyperhidrosis). Patients may also develop skin tags and a coarse facial texture.
Hypertension, left ventricular hypertrophy, and sleep‑disordered breathing (including obstructive sleep apnea) are frequent systemic effects. These are driven by both direct hormonal actions and secondary metabolic disturbances.
Overall, the constellation of physical signs provides a practical framework for early detection. When multiple features appear together—especially facial bone changes and enlarged extremities—clinicians should promptly assess the underlying hormonal drivers.
Beyond the visible alterations, the symptoms and hormonal imbalance in acromegaly exerts profound effects on metabolism, organ function, and quality of life. Understanding these systemic consequences helps patients anticipate potential complications and cooperate with their care team.
Elevated GH antagonizes insulin action, promoting hepatic gluconeogenesis and peripheral insulin resistance. Approximately 30 % of acromegaly patients develop impaired glucose tolerance, and up to 15 % progress to overt type 2 diabetes.
Chronic exposure to high IGF‑1 levels leads to myocardial hypertrophy, reduced diastolic function, and an increased risk of arrhythmias. Hypertension is reported in more than half of untreated patients.
Soft‑tissue overgrowth in the pharyngeal region narrows the airway, predisposing individuals to obstructive sleep apnea. This can exacerbate daytime fatigue and cardiovascular strain.
A quick reference of systemic complications is presented in the table below:
Addressing these systemic issues early—through hormonal control and targeted lifestyle measures—greatly improves long‑term outcomes.
Accurate detection of the symptoms and hormonal profile requires a combination of clinical evaluation, biochemical testing, and imaging studies. Early diagnosis shortens the period of uncontrolled hormone exposure and reduces irreversible tissue changes.
The cornerstone tests include:
Magnetic resonance imaging (MRI) of the sellar region is the gold standard for visualizing pituitary adenomas. Microadenomas (< 10 mm) and macroadenomas (> 10 mm) are differentiated, guiding surgical planning.
The following flowchart outlines the step‑wise approach:
Liv Hospital’s endocrinology department offers a streamlined pathway for international patients, including interpreter‑supported consultations and fast‑track imaging appointments.
Effective control of the symptoms and hormonal disturbances hinges on normalizing GH and IGF‑1 levels while addressing the secondary complications that have already developed.
First‑line pharmacologic options include:
Transsphenoidal surgery remains the definitive treatment for most pituitary adenomas, especially when the tumor is well‑circumscribed. Success rates exceed 70 % for microadenomas when performed by experienced neurosurgeons.
For residual disease after surgery or when medical therapy is insufficient, stereotactic radiosurgery offers a non‑invasive option, albeit with a delayed hormonal response.
Patients should adopt measures that mitigate cardiovascular and metabolic risks:
Liv Hospital provides a multidisciplinary follow‑up program that includes endocrinologists, cardiologists, nutritionists, and physiotherapists, ensuring a coordinated approach to symptom relief and hormonal balance.
Prompt referral to a center experienced in endocrine disorders is advisable when any of the following symptoms and hormonal clues appear:
Liv Hospital’s international patient services streamline the entire journey:
Choosing a JCI‑accredited institution like Liv Hospital guarantees adherence to global safety standards and access to cutting‑edge therapies that target both the hormonal root cause and the associated symptoms.
Liv Hospital combines world‑class expertise with a patient‑centred approach designed for international visitors. Our endocrinology team has extensive experience diagnosing and treating acromegaly, leveraging advanced imaging, minimally invasive surgery, and personalized medication regimens. Complementary services—including interpreter support, coordinated transportation, and comfortable lodging—ensure a seamless experience from the moment you arrive in Istanbul to your post‑treatment follow‑up.
Ready to take control of your health? Contact Liv Hospital today to schedule a comprehensive endocrine evaluation and start your journey toward symptom relief and hormonal balance.
Send us all your questions or requests, and our expert team will assist you.
Acromegaly often presents with progressive facial changes such as prognathism (protruding lower jaw), macroglossia (enlarged tongue), and a broader nose. The hands and feet may grow noticeably, requiring larger shoes and rings. Skin can become oily and thickened, and patients may develop skin tags. These manifestations result from excess IGF‑1 stimulating periosteal bone growth and soft‑tissue expansion.
Elevated growth hormone promotes hepatic gluconeogenesis and reduces peripheral glucose uptake, creating a state of insulin resistance. Approximately 30 % of acromegaly patients develop impaired glucose tolerance, and up to 15 % progress to overt type 2 diabetes. Monitoring fasting glucose and HbA1c is essential for early intervention.
The diagnostic work‑up starts with a random GH measurement; values above 20 µg/L are highly suggestive. An IGF‑1 assay, adjusted for age and sex, confirms chronic GH excess when elevated. The oral glucose tolerance test (OGTT) assesses GH suppression; in healthy individuals GH falls below 1 µg/L after glucose load, whereas failure to suppress indicates acromegaly.
Somatostatin analogues such as octreotide and lanreotide inhibit GH secretion and can shrink pituitary tumors. GH receptor antagonists like pegvisomant block peripheral IGF‑1 production, improving metabolic parameters. Dopamine agonists (e.g., cabergoline) may be effective in patients with modest GH excess, often as adjunct therapy.
Transsphenoidal surgery offers the highest chance of cure for microadenomas (< 10 mm) and many macroadenomas when the tumor is accessible and not invasive. Success rates exceed 70 % for experienced surgeons. Surgery is usually the first option when imaging shows a discrete tumor and the patient is a suitable surgical candidate.
Patients should adopt a diet low in simple sugars and saturated fats to mitigate insulin resistance and cardiovascular risk. Engaging in at least 150 minutes of moderate aerobic activity per week improves metabolic health. Quarterly checks of blood pressure, fasting glucose, and IGF‑1 levels help track disease control. Physiotherapy can alleviate joint pain and carpal tunnel symptoms.
BlogEndocrinologyApr 14, 2026Understand the impact of elevated cortisol on your blood pressure and learn how to keep cortisol levels in ...
BlogEndocrinologyApr 14, 2026Discover the causes and effects of persistent hyponatremia, and learn how low sodium levels can impact your...
BlogEndocrinologyApr 13, 2026Discover the essential role of antidiuretic hormone (ADH) in regulating fluid balance. Our complete guide e...
BlogEndocrinologyApr 13, 2026Learn about SIADH, the condition where your body produces too much antidiuretic hormone. Discover causes, s...
BlogEndocrinologyApr 13, 2026Understand the role of an endocrinologist and when to seek their expertise. Get insights on what is polydip...
BlogEndocrinologyApr 13, 2026Discover the benefits and uses of estrogen patches. Our guide explains the meaning of polyuria and how this...
Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.
Start Chat on WhatsApp or call us at +90 530 510 71 24
